Todd C Brady Insider Trading $ALDX Aldeyra Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Todd C Brady.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Todd C Brady. Todd C Brady is President and CEO in Aldeyra Therapeutics, Inc. ($ALDX) and Director in Evoke Pharma Inc ($EVOK) and Director in Spring Bank Pharmaceuticals, Inc. ($SBPH) and in Oncobiologics, Inc. ($ONS) and Director in Oncobiologics, Inc. ($ONS).
Todd C Brady in Aldeyra Therapeutics, Inc.
Trading Symbol: ALDXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Todd C Brady: President and CEO
Holdings: 948,835 shares
Current Value: $4,744,175
Latest Transaction: Apr 14 2021
$ALDX Market Capitalization: $30.29M
$ALDX Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Todd C Brady in Aldeyra Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALDX, EVOK, SBPH, OTLKW
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 14 2021 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 11.71 | 250,000 | 2,927,500 | 250,000 | |
Apr 14 2021 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 46,619 | 0 | 948,835 | 902.2 K to 948.8 K (+5.17 %) |
Mar 04 2020 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 3.78 | 450,865 | 1,704,270 | 450,865 | |
Mar 04 2020 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 3.78 | 250,000 | 945,000 | 250,000 | |
Mar 04 2020 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 250,000 | 0 | 902,216 | 652.2 K to 902.2 K (+38.33 %) |
Dec 18 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.10 | 20,000 | 101,908 | 652,216 | 632.2 K to 652.2 K (+3.16 %) |
Oct 02 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.68 | 8,710 | 49,483 | 632,216 | 623.5 K to 632.2 K (+1.40 %) |
Sep 25 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.81 | 8,680 | 50,433 | 623,506 | 614.8 K to 623.5 K (+1.41 %) |
Sep 20 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.91 | 14,288 | 84,465 | 614,826 | 600.5 K to 614.8 K (+2.38 %) |
Sep 17 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 6.03 | 3,000 | 18,090 | 591,991 | 589 K to 592 K (+0.51 %) |
Sep 17 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.79 | 10,000 | 57,900 | 588,991 | 579 K to 589 K (+1.73 %) |
Sep 11 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.39 | 10,000 | 53,937 | 578,991 | 569 K to 579 K (+1.76 %) |
Sep 11 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 4.89 | 10,000 | 48,887 | 568,991 | 559 K to 569 K (+1.79 %) |
Mar 07 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 8.05 | 45,329 | 364,898 | 45,329 | |
Mar 07 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 8.05 | 250,000 | 2,012,500 | 250,000 | |
Mar 07 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 250,000 | 0 | 556,054 | 306.1 K to 556.1 K (+81.68 %) |
Mar 08 2018 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 8.60 | 217,293 | 1,868,720 | 217,293 | |
Mar 08 2018 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 101,269 | 0 | 302,483 | 201.2 K to 302.5 K (+50.33 %) |
Mar 07 2017 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 5.10 | 250,000 | 1,275,000 | 250,000 | |
Mar 07 2017 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 136,806 | 0 | 201,214 | 64.4 K to 201.2 K (+212.41 %) |
Feb 21 2017 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 4.50 | 22,223 | 100,004 | 64,408 | 42.2 K to 64.4 K (+52.68 %) |
May 05 2016 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 27,096 | 0 | 42,185 | 15.1 K to 42.2 K (+179.57 %) |
Mar 18 2016 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 4.59 | 300,000 | 1,377,000 | 300,000 | |
Jun 05 2015 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 7.85 | 90,000 | 706,500 | 90,000 |
Page: 1